Breaking News

Goodwin Biotechnology Completes cGMP Manufacturing of an IgM Monoclonal Antibody

Successful clearance of Q Therapeutics' IND submission for Q-Cells cell therapy in ALS

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Goodwin Biotechnology, Inc., a biological contract development and manufacturing organization (CDMO) that specializes in bioprocess development and GMP manufacturing of biopharmaceuticals utilizing mammalian cell culture expression systems and bioconjugation technologies, has partnered with Q Therapeutics, Inc., a clinical-stage developer of novel cellular therapies for central nervous system (CNS) diseases to provide GMP antibodies for manufacture of clinical trial materials. To do so, Goodwin ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters